Refine your search with filters

All-Materials All
Congress-AbstractsCongress Abstracts
Tools-SkillsTools & Skills
PublicationsPublications
Congress-SlidesCongress Presentations
Videos-PodcastsVideos & Podcasts

Quicksearch

N032: Impact of pain due to subcutaneous administration of a biological drugECCO '18 Vienna
Year: 2018
Authors:

C. Gely1, L. Marin2, J. Gordillo1*, M. Mañosa2,3, F. Bertoletti1, F. Cañete2, C. Gonzalez-Muñosa1, E. Cabré2,3, E. Domènech2,3, E. Garcia-Planella1

1Hospital de la Santa Creu i Sant Pau, Barcelona, Spain, 2Hospital Universitari Germans Trias i Pujol, Badalona, Spain, 3Centro de Investigación Biomédica en Red en el Área temática de Enfermedades Hepáticas (CIBEREHD), Barcelona, Spain

N033: Young adults living with inflammatory bowel disease. A thematic synthesis of patient experienceECCO '18 Vienna
Year: 2018
Authors:

S. Fourie1,2*, D. Jackson1, H. Aveyard1, A. Simmons2

1Oxford Brookes University, Oxford Institute of Nursing, Midwifery and Allied Health Research, Oxford, UK, 2University of Oxford, Nuffield Department of Medicine, Oxford, UK

N034: Patient satisfaction with brand changes of Mesalazine medications in four hospitals in the North West of EnglandECCO '18 Vienna
Year: 2018
Authors:

R. Campbell1*, E. Nelson2, J. Hocking3, J. Hodgins4, T. Hickey3, V. Geraghty5

1Stockport Acute Foundation Trust, Gastroenterology, Stockport, UK, 2Macclesfield Hospital, Gastroenterology, Macclesfield, UK, 3Royal Blackburn Hospital, Gastroenterology, Blackburn, UK, 4University Hospital Of South Manchester, Gastroenterology, Manchester, UK, 5University Of South Manchester, Gastroenterology, Manchester, UK

N035: The use of intravenous (IV) ferric carboxymaltose in a paediatric IBD populationECCO '18 Vienna
Year: 2018
Authors:

K. Crook*, T. Tyrrell, W. Hyer

St Mark's Hospital, Paediatric Gastroenterology, Harrow, UK

N036: The advanced nursing care in IBD: Study on biosimilar drugsECCO '18 Vienna
Year: 2018
Authors:

F.M. Onidi*, S. Simbula, V. Vacca, L. Binaghi, M. Pellecchia, F. Cabras, M. Demurtas, G. Mocci

Gastroenterology Unit Brotzu Hospital, Cagliari, Italy

N037: Attitudes of Crohn’s disease patients toward self-monitoring trough an AppECCO '18 Vienna
Year: 2018
Authors:

M.C. Morete Pérez*, V. Ollero, R. Fraga, A. Lopez, A. Echarri

Complejo Hospitalario Universitario de Ferrol, Unidad de EICI, Servicio de Digestivo, Ferrol, Spain

NO001: Cognitive behavioural therapy for the management of inflammatory bowel disease-fatigue: A pilot randomised controlled trial12th N-ECCO Network Meeting
Year: 2018
Authors:

M. Artom*, W. Czuber-Dochan, J. Sturt, H. Proudfoot, C. Norton

King's College London, Florence Nightingale Faculty of Nursing and Midwifery, London, UK

NO002: Increasing research capacity of IBD nurses across Europe—a case study of Inflammatory Bowel Disease Fatigue (IBD-F) scale translation and validation12th N-ECCO Network Meeting
Year: 2018
Authors:

W. Czuber-Dochan1*, M. Artom1, C. Norton1, A. Andonova2, M. Pencova2, V. Cluzeau3, M. Chalabreysee3, R. Barkan4, I. Goren4, L. Shpoker5, S. Radice6, E. Schiavoni7, A. Cocchieri8, D. Napolitano9, L. Turchini9, M. Zega9, L.P. Jelsness-Jørgensen10, A. Giner-Agudo11, R. Barastegui11, C. Fernández-Fernández12, M. Gallego11, F. Murciano13, E. Navarro14, A. Rivera15, A. Vara-Hernández16, S. Jäghult17, K. Pihl Lesnovska17, A. der Heer-Damen18, A. Heil18, L. Moortgat19

1King's College London, Faculty of Life Sciences and Medicine, Department of Nutritional Sciences, London, UK, 2Trakia University, Faculty of Medicine, Stara Zagora, Bulgaria, 3Hôpital Archet2- 4èmeB- CHU de Nice, Pôle digestif- Nutrition Clinique, Nice, France, 4Rabin Medical Center - Beilinson Hospital, Department of Gastroenterology, Petah Tikva, Israel, 5Bnai Zion Medical Center, Gastroenterology Department, Haifa, Israel, 6Instituto Clinico Humanitas, Rozzano, Italy, 7Fondazione Policlinico Universitario Agostino Gemelli, Gastroenterology and Hepatology Group, Roma, Italy, 8Fondazione Policlinico Universitario Agostino Gemelli, Gastroenterology and Hepatology, Rome, Italy, 9Fondazione Policlinico Universitario Agostino Gemelli, Gastroenterology and Hepatology, Roma, Italy, 10Ostfold University College, Halden, Norway, 11Hospital Clinic Barcelona, Gastroenterology, Barcelona, Spain, 12Hospital Ramón y Cajal, Gastroenterology, Madrid, Spain, 13Hospital del Mar, IBD and Digestology Department, Barcelona, Spain, 14Vall Hebron Universitary Hospita, IBD Unit Gastroenterology Department, Barcelona, Spain, 15Hospital San Juan de Dios del Aljarafe, Internal Medicine, Seville, Spain, 16Hospital Clínic de Barcelona, IBD Unit Gastroenterology Department, Barcelona, Spain, 17Stockholm Gastro Center, Stockholm, Sweden, 18Elisabeth-TweeSteden Ziekenhuis, Gastroenterology and Hepatology, Tilburg, The Netherlands, 19Az Delta Hospital, Roeselare, Belgium

NO003: The quality of care questionnaire—development of a valid measure for persons with inflammatory bowel disease12th N-ECCO Network Meeting
Year: 2018
Authors:

K. Pihl Lesnovska1*, S. Börjeson2, G. Hollman Frisman3, H. Hjortswang4, M. Wenemark5

1University hospital of Linköping, Gastroenterology and hepatology, Linköping, Sweden, 2Faculty of Medicine, Linköping University, Department of Medical and Health Sciences, Linköping, Sweden, 3Department of Medical and Health Sciences, Linköping University, Department of Anaesthesiology and Intensive Care, Linköping, Sweden, 4Clinical and Experimental Medicine, Linköping University, Department of Gastroenterology and Department, Linköping, Sweden, 5Department of Medical and Health Sciences, Linköping University, Centre for Organisational support and Development, Linköping, Sweden

OP001: Gut barrier dysfunction: a primary defect in twins with Crohn’s disease predominantly caused by genetic predispositionECCO '18 Vienna
Year: 2018
Authors:

Å.V. Keita1, C.M. Lindqvist2, Å. Öst3, C.D.L. Magana1, I. Schoultz2, J. Halfvarson4*

1Linköping University, Department of Clinical and Experimental Medicine, Linköping, Sweden, 2Örebro University, Department of Medical Sciences, Örebro, Sweden, 3Aleris Medilab, Department of Pathology and Cytology, Täby, Sweden, 4Örebro University, Department of Gastroenterology, Örebro, Sweden

OP002: Assessment of disease activity patterns during the first 10 years after diagnosis in a population-based Crohn’s disease cohort shows a quiescent disease course for a substantial proportion of the populationECCO '18 Vienna
Year: 2018
Authors:

D. Wintjens1,2*, F. Bergey3, E. Saccenti4, S. Jeuring1,2, M. Romberg-Camps5, L. Oostenbrug5, A. Masclee1,2, D. Jonkers1,2, V. Martins dos Santos3,4, M. Pierik1,2

1Maastricht University Medical Center, Department of Internal Medicine, Division of Gastroenterology and Hepatology, Maastricht, The Netherlands, 2Maastricht University Medical Center, NUTRIM School for Nutrition and Translational Research in Metabolism, Maastricht, The Netherlands, 3LifeGlimmer GmbH, Berlin, Germany, 4Wageningen University & Research, Laboratory of Systems and Synthetic Biology, Wageningen, The Netherlands, 5Zuyderland Medical Centre, Department of Gastroenterology and Hepatology, Sittard-Geleen/Heerlen, The Netherlands

OP003: Temporal changes in immune pathways with consecutive biological therapies as measured by serum proteomicsECCO '18 Vienna
Year: 2018
Authors:

M. de Bruyn1,2*, V. Ballet3, S. Verstockt4, B. Verstockt1,3, G. Van Assche1,3, M. Ferrante1,3, K. Machiels1, S. Vermeire1,3

1Translational Research Center for GastroIntestinal Disorders (TARGID), Chronic Diseases, Metabolism and Ageing (CHROMETA), Leuven, Belgium, 2Rega Institute for Medical Research, Microbiology and Immunology, Leuven, Belgium, 3University Hospitals Leuven, Gastroenterology and Hepatology, Leuven, Belgium, 4Laboratory of Complex Genetics, Human Genetics, Leuven, Belgium

OP004: The TLR9 agonist cobitolimod induces anti-inflammatory effects and balances the Th17/T-reg cell response in ulcerative colitisECCO '18 Vienna
Year: 2018
Authors:

H. Schmitt1*, U. Billmeier1, J. Ulmschneider1, C. Admyre2, T. Knittel2, A. Zargari2, M.F. Neurath1, R. Atreya1

1Friedrich-Alexander-University Erlangen-Nürnberg, First Department of Medicine, Erlangen, Germany, 2InDex Pharmaceuticals AB, Stockholm, Sweden

OP005: Apremilast for active ulcerative colitis: a phase 2, randomised, double-blind, placebo-controlled induction studyECCO '18 Vienna
Year: 2018
Authors:

S. Danese1*, M. Neurath2, A. Kopon3, S. Zakko4, T. Simmons5, R. Fogel6, J. Maccarone7, X. Zhan7, K. Usiskin7, D. Chitkara7

1Instituto Clinico Humanitas, Milan, Italy, 2University Erlangen, Nurnberg, Germany, 3Torunskie Centrum Gastrologiczne Gastromed, Torun, Poland, 4Connecticut Clinical Research Foundation of Bristol Hospital, Bristol, USA, 5West Gastroenterology Medical Group, Los Angeles, USA, 6Clinical Research Institute of Michigan, Chesterfield, USA, 7Celgene Corporation, Summit, USA

OP006: Higher anti-TNF serum levels are associated with perianal fistula closure in Crohn’s disease patientsECCO '18 Vienna
Year: 2018
Authors:

A. Strik1*, M. Löwenberg1, C. Ponsioen1, K. Gecse2, C. Buskens3, W. Bemelman3, G. D’Haens1

1Academic Medical Center, Gastroenterology and Hepatology, Amsterdam, The Netherlands, 2Academic Medical Center (AMC), Department of Gastroenterology and Hepatology, Amsterdam, The Netherlands, 3Academic Medical Center (AMC), Department of Surgery, Amsterdam, The Netherlands

OP007: α4β7 Integrin-dependent gut homing of non-classical monocytes is essential for intestinal wound healing mediated by M2 macrophagesECCO '18 Vienna
Year: 2018
Authors:

L. Schleier1, M. Wiendl1, M.-T. Binder1, R. Atreya1, A. Watson2, C. Neufert1, I. Atreya1, M.F. Neurath1, S. Zundler1*

1University of Erlangen-Nuremberg, Department of Medicine I, Erlangen, Germany, 2University of East Anglia, Norwich Medical School, Norwich, UK

OP008: Detection of mucosal healing with a serum marker panel in adalimumab-treated patients with ulcerative colitisECCO '18 Vienna
Year: 2018
Authors:

M. de Bruyn1,2*, R. Ringold3, E. Martens2, M. Ferrante1,4, G. Van Assche1,4, G. Opdenakker2, A. Dukler3, S. Vermeire1,4

1Translational Research Center for GastroIntestinal Disorders (TARGID), Chronic Diseases, Metabolism and Ageing (CHROMETA), Leuven, Belgium, 2Rega Institute for Medical Research, Microbiology and Immunology, Leuven, Belgium, 3Kepler Diagnostics, Inc., Simi Valley, USA, 4University Hospitals Leuven, Gastroenterology and Hepatology, Leuven, Belgium

OP009: A combination of clinical, serological, and genetic factors predicts complicated disease course in paediatric-onset Crohn’s disease: results from a population-based studyECCO '18 Vienna
Year: 2018
Authors:

H. Sarter1,2*, G. Savoye3, D. Turck2,4, F. Vasseur5, G. Marot6,7, B. Pariente2,8, S. Singh9, J.F. Colombel10, C. Gower-Rousseau1,2, M. Fumery11

1Lille Hospital and University, Public Health, Epidemiology and Economic Health, Epimad Registry, Regional House of Clinical Research, Lille, France, 2Lille University, Lille Inflammation Research International Center LIRIC-UMR 995 Inserm, Lille, France, 3Rouen Hospital and University, Gastroenterology Unit, Epimad Registry, Rouen, France, 4Lille University Jeanne de Flandre Children’s Hospital and Faculty of Medicine, Division of Gastroenterology, Hepatology and Nutrition, Department of Pediatrics, Lille, France, 5Lille University and Hospital, Biostatistics Unit, EA 2694, Lille, France, 6Lille University and Hospital, EA 2694 - Santé publique : épidémiologie et qualité des soins, Lille, France, 7Inria Lille Nord Europe, Modal, Lille, France, 8Gastroenterology Unit, Epimad Registry, Lille Hospital and University, Lille, France, 9Prometheus Laboratories Inc., San Diego, USA, 10Icahn School of Medicine at Mount Sinai, Division of Gastroenterology, New York, USA, 11Amiens Hospital and University, Gastroenterology Unit, EPIMAD Registry, Amiens, France

OP010: Shallow whole-genome sequencing predicts the future cancer risk of low-grade dysplastic lesions arising in ulcerative colitisECCO '18 Vienna
Year: 2018
Authors:

I. Al Bakir1,2*, K. Curtius1, A.-M. Baker1, T.S.O. Clarke1, M. Moorghen3, M. Jansen4, M. Rodriguez-Justo4, S. Leedham5, T. Graham1*, A. Hart2*

1Queen Mary University of London, Barts Cancer Institute, London, UK, 2St. Mark’s Hospital, Inflammatory Bowel Disease Unit, Harrow, UK, 3St. Mark’s Hospital, Pathology Department, Harrow, UK, 4University College London Hospital, Pathology Department, London, UK, 5Henry Wellcome Building of Genomic Medicine, Wellcome Trust Centre for Human Genetics, Oxford, UK

OP011: Integration of whole-exome sequencing and RNA sequencing of intestinal biopsies in inflammatory bowel disease identifies inflammation-dependent effectsECCO '18 Vienna
Year: 2018
Authors:

R. Barbieri1*, W. Uniken Venema1, A. Vich Vila1, Y. Li1, L. Franke1, F. van Dijk1, N. De Klein1, M. Swertz1, S. Sanna1, M.D. Voskuil1, M. Rivas2, R. Xavier2, M. Daly2, G. Dijkstra1, E.A. Festen1, R.K. Weersma1

1UMCG, Groningen, The Netherlands, 2The Broad Institute of MIT and Harvard, Cambridge, USA